Authors
Latest:
Differences in Effective Therapies for Pediatric versus Adults with MS: Brenda Banwell, MDThe chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke at ECTRIMS 2022 about the difference in conversation for therapies between pediatric patients and adult patients with MS. [WATCH TIME: 5 minutes]
Latest:
FDA Approves Pfizer COVID-19 Vaccine for Those Ages 16 Years and OlderThe full approval for BNT162b2 (Comirnaty; Pfizer/BioNTech) will afford physicians greater prescribing capability and is expected to play a role in driving workplace vaccine mandates.
Latest:
The Case for NeurorehabilitationNeurological rehabilitation, or neurorehabilitation, can be described as the use of rehabilitation interventions to improve or maintain function and quality of life in the context of neurological conditions.
Latest:
Significant Impact of Carbidopa Levodopa Agent ND0162 in Parkinson Disease: Alberto J. Espay, MD, MScThe director of the James J. and Joan A. Gardner Family Center discussed data from the phase 3 BouNDless trial assessing a continuous, subcutaneous levodopa/carbidopa delivery system for patients with Parkinson disease experiencing motor fluctuations. [WATCH TIME: 3 minutes]
Latest:
Future Treatment of hATTR AmyloidosisAnalysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
Latest:
Jeff D. Williamson, MD, MHS: SPRINT-MIND Trial Preliminary ResultsThe SPRINT MIND trial found a statistically significant lower rate of new cases of mild cognitive impairment in the intensive treatment group.
Latest:
Elzbieta Kuzma, PhD: Healthy Lifestyle Reduces Dementia Risk Despite GeneticsThe research fellow at the University of Exeter spoke about the findings from her observational study which showed that living a favorable lifestyle could offset the risk for dementia, even if that risk is genetically linked. 


Latest:
Use of Narcolepsy Treatments in Different Patients: Part 1Drs Thorpy, Dogan, Doghramji, and Kushida detail which medications to use in various patients with narcolepsy.
Latest:
Amy Sullivan, PysD: Team-Based Approach to MSThe director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about the importance of caring for patients with MS by using a team-based approach.
Latest:
Paroxysmal Abnormalities in the Brain and Defining the ‘Seizure’: Michael Sperling, MDAt the 2022 AES Conference, the Baldwin Keyes professor of neurology at Thomas Jefferson University, talked about what defines a ‘seizure’ and changing the terminology. [WATCH TIME: 5 minutes]
Latest:
J. Eric Pina-Garza, MD: Increasing the Awareness of EpilepsyThe director of Pediatric Epilepsy at Centennial Children's Hospital spoke about the need to increase epilepsy's awareness and the clinical development of several agents that he is keeping his eyes on.
Latest:
Lilyana Amezcua, MD: Better Understanding MS in the Hispanic CommunityThe associate professor of clinical neurology spoke about the need to understand modifiable social and cultural factors that could impact disease severity and progression.
Latest:
Hannah Cock, MD, MBBS: Challenges in Treating Status EpilepticusThe professor of epilepsy and medical education at St. George’s University Hospital London spoke about the number of challenges plaguing epileptologists when treating patients who present with possible status epilepticus in the hospital.
Latest:
Rare Neurologic Diseases Are Not Truly RareDespite being labeled as rare diseases, a number of neurologic conditions impact more patients than most would believe. The consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases, chimed in about how these diseases can often be overlooked.
Latest:
Sumeet Vadera, MD: Advances in Epilepsy SurgeryThe director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.
Latest:
Rebecca Stainman, MD: Identifying, Addressing Physician BurnoutThe child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
Latest:
Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug DevelopmentHaeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.
Latest:
A Holistic Approach to Preserving Brain Health: Costantino Iadecola, MDThe director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine discussed ways to use a comprehensive approach when maintaining brain health. [WATCH TIME: 7 minutes]
Latest:
Samantha Budd Haeberlein, PhD: The TANGO II Trial of BIIB092The vice president and head of Alzheimer’s Disease, Dementia, and Movement Disorders in Late Stage Clinical Development at Biogen spoke about the upcoming TANGO II trial in Alzheimer disease.
Latest:
Ozanimod's Consistent Efficacy in Long-Term Treatment for Multiple Sclerosis: Jeffery Cohen, MDThe director of Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research talked about recent findings on long-term impact of ozanimod in patients with relapsing-remitting multiple sclerosis presented at ACTRIMS Forum 2024. [WATCH TIME: 4 minutes]
Latest:
Anthony Fiorino, MD, PhD: Using nVNS in Various Migraine PopulationsThe chief medical officer of electroCore discussed the various data which have been published on the use of noninvasive vagus nerve stimulation in different populations of patients with migraine and headache.
Latest:
Fernando Dangond, MD, MBA: Phase 2 Data on Evobrutinib in MSHead of Global Clinical Development in Neurology at EMD Serono discussed the findings of a phase 2 assessment of the company’s investigational BTK inhibitor evobrutinib in multiple sclerosis.
Latest:
AUPN 2022 Women Leaders in NeurologyLaurie Gutmann, MD; Gauri Pawar, MD; and Claire Henchcliffe, MD, discuss their own paths in medicine and observations of other women leaders. [WATCH TIME: 1 hour, 51 minutes]
Latest:
Antiplatelets Versus Anticoagulation For the Treatment of Cervical Artery Dissection: Shadi Yaghi, MDThe associate professor of neurology at Brown University talked about findings from an observational study investigating treatment options antiplatelets and anticoagulation for cervical artery dissection. [WATCH TIME: 8 minutes]
Latest:
Andrew Satlin, MD: Lumateperone for Agitation in Patients with Dementia, Alzheimer DiseaseData from an interim analysis of the lumateperone large phase III clinical trial for agitation in subjects with dementia is expected by the end of 2018.
Latest:
Kelvin Tsoi, PhD: Combination Therapy, Monotherapy in Alzheimer DiseaseAfter identifying and reviewing 76 randomized trials, combination therapy with memantine and AChEIs is confirmed to have no additional benefits over monotherapy.
Latest:
Exploring the Burden of Cerebrovascular Disease in VirginiaLocated in the “Stroke Belt” of the US, Virginia presents a unique perspective on the interplay of social, ethnic, and cultural implications on population health.
